1. Home
  2. CAL vs VNDA Comparison

CAL vs VNDA Comparison

Compare CAL & VNDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Caleres Inc.

CAL

Caleres Inc.

HOLD

Current Price

$12.77

Market Cap

449.1M

ML Signal

HOLD

Logo Vanda Pharmaceuticals Inc.

VNDA

Vanda Pharmaceuticals Inc.

HOLD

Current Price

$5.21

Market Cap

361.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CAL
VNDA
Founded
1878
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Shoe Manufacturing
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
449.1M
361.4M
IPO Year
1994
2005

Fundamental Metrics

Financial Performance
Metric
CAL
VNDA
Price
$12.77
$5.21
Analyst Decision
Buy
Strong Buy
Analyst Count
2
5
Target Price
$15.00
$14.90
AVG Volume (30 Days)
543.6K
626.6K
Earning Date
05-28-2026
05-06-2026
Dividend Yield
2.13%
N/A
EPS Growth
N/A
N/A
EPS
2.14
N/A
Revenue
$85,513,000.00
$216,105,000.00
Revenue This Year
$5.19
$21.35
Revenue Next Year
$2.45
$37.40
P/E Ratio
$5.57
N/A
Revenue Growth
0.46
8.72
52 Week Low
$8.80
$4.27
52 Week High
$15.04
$9.91

Technical Indicators

Market Signals
Indicator
CAL
VNDA
Relative Strength Index (RSI) 50.11 45.89
Support Level $11.61 $4.94
Resistance Level $14.06 $5.62
Average True Range (ATR) 0.69 0.17
MACD 0.01 -0.01
Stochastic Oscillator 44.36 27.14

Price Performance

Historical Comparison
CAL
VNDA

About CAL Caleres Inc.

Caleres Inc is a footwear company that operates retail shoe stores and e-commerce websites, and designs, develops, sources, manufactures, and distributes footwear for people of all ages. The Company's business operations are organized into two reportable segments - Famous Footwear and Brand Portfolio. The Famous Footwear segment is comprised of its Famous Footwear retail stores, famousfootwear.com, and famousfootwear.ca. The Brand Portfolio segment offers retailers and consumers a cultivated portfolio of known brands. This segment is comprised of wholesale operations that designs, develops, sources, manufactures, markets and distributes branded, licensed and private-label footwear. Geographically, the company generates the majority of its revenue from Domestic operations.

About VNDA Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include ASO Molecules, VQW-765, Tradipitant, and VTR-297. The maximum of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.

Share on Social Networks: